Results 211 to 220 of about 213,320 (307)
ABSTRACT This paper examines the impacts of Volume‐Based Procurement (VBP) policies on pharmaceutical supply chains, with a focus on the strategic behaviors of manufacturers. VBP aims to reduce costs and stabilize supplies by centralizing procurement through competition based on volumes and prices.
Nani Zhou, Tong Wang, Guohua Wan
wiley +1 more source
Access in all areas? A round-up of developments in market access and health technology assessment: part 12. [PDF]
Ramagopalan SV, Pannelay AJ.
europepmc +1 more source
Medicaid Expansion and Retail Pharmacy Availability.
Kakani P +4 more
europepmc +1 more source
Securitization as a means to pay for cell and gene therapies for orphan diseases: a simulation study. [PDF]
Lu JM +3 more
europepmc +1 more source
Programs in Pharmaceutical Economics
openaire +1 more source
Phlorotannins from Phaeophyceae: Structural Diversity, Multi-Target Bioactivity, Pharmacokinetic Barriers, and Nanodelivery System Innovation. [PDF]
Harasym J, Słota P, Pejcz E.
europepmc +1 more source
Microcrystalline cellulose (MCC) was extracted from watermelon rind using acid hydrolysis. MCC can be efficiently used as reinforcement in biofilms and biocomposites. Abstract The increasing accumulation of agricultural waste from watermelon (Citrullus lanatus) represents a substantial environmental concern, particularly in view of the extensive ...
Indran Suyambulingam +7 more
wiley +1 more source
Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries. [PDF]
Kaló Z +25 more
europepmc +1 more source
Thirty years of glyphosate‐resistant crops and weeds: Current situation and future prospects
Since 1996, when the first glyphosate‐resistant crop was commercialized and the first resistant weed was reported, resistance has expanded globally. This review analyzes emergence patterns across weed species, crops, regions, resistance mechanisms, and herbicides.
Ricardo Alcántara‐de la Cruz +7 more
wiley +1 more source

